These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of the local application of 3-PPP and sulpiride enantiomers into the nucleus accumbens or into the ventral tegmental area on rat locomotor activity: evidence for the functional importance of somatodendritic autoreceptors. Ahlenius S. Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):516-22. PubMed ID: 1356231 [Abstract] [Full Text] [Related]
4. Sulpiride blocks postsynaptic dopamine receptors in the nucleus accumbens. Morgenstern R, Fink H. J Neural Transm; 1985 May; 61(3-4):151-60. PubMed ID: 3989521 [Abstract] [Full Text] [Related]
5. Neuropharmacological evidence to suggest that the nucleus accumbens and subpallidal region contribute to exploratory locomotion. Mogenson GJ, Nielsen M. Behav Neural Biol; 1984 Sep; 42(1):52-60. PubMed ID: 6508693 [Abstract] [Full Text] [Related]
6. Alterations of accumbens neuronal activity in freely moving rats following methamphetamine. Fukuzako H, Nagatomo I, Nomaguchi M, Takenouchi K, Matsumoto K. Jpn J Psychiatry Neurol; 1988 Jun; 42(2):331-5. PubMed ID: 2853805 [Abstract] [Full Text] [Related]
8. Biphasic locomotor response to intra-accumbens dopamine in a nonhuman primate. Jones DL, Berg SL, Dorris RL, Dill RE. Pharmacol Biochem Behav; 1981 Aug; 15(2):243-6. PubMed ID: 7198267 [Abstract] [Full Text] [Related]
9. [Circling behavior produced by the unilateral intra-accumbens injection of dopaminergic agonist and two dopaminergic antagonists in mice]. Mrabet O, Messier C, Destrade C. C R Acad Sci III; 1989 Aug; 309(3):77-82. PubMed ID: 2504444 [Abstract] [Full Text] [Related]
11. Effect of a novel environment on locomotor hyperactivity of rats induced by apomorphine in the nucleus accumbens. Morgenstern R, Fink H. Biomed Biochim Acta; 1985 Aug; 44(10):1517-22. PubMed ID: 4084255 [Abstract] [Full Text] [Related]
12. Attenuation of dark-induced hyperlocomotion by a cholecystokinin antagonist in the nucleus accumbens. Crawley JN. Brain Res; 1988 Nov 15; 473(2):398-400. PubMed ID: 3233498 [Abstract] [Full Text] [Related]
13. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Dreher JK, Jackson DM. Brain Res; 1989 May 22; 487(2):267-77. PubMed ID: 2525062 [Abstract] [Full Text] [Related]
14. Suppression of exploratory locomotor activity and increase in dopamine turnover following the local application of cis-flupenthixol into limbic projection areas of the rat striatum. Ahlenius S, Hillegaart V, Thorell G, Magnusson O, Fowler CJ. Brain Res; 1987 Jan 27; 402(1):131-8. PubMed ID: 3828778 [Abstract] [Full Text] [Related]
15. Effects of haloperidol and sulpiride on dopamine-induced inhibition of nucleus accumbens neurons. Akaike A, Sasa M, Takaori S. Life Sci; 1983 Jun 06; 32(23):2649-53. PubMed ID: 6855460 [Abstract] [Full Text] [Related]
16. The effect of cholinergic stimulation in the nucleus accumbens on locomotor behavior. Austin MC, Kalivas PW. Brain Res; 1988 Feb 16; 441(1-2):209-14. PubMed ID: 3359231 [Abstract] [Full Text] [Related]
17. Effects of microinjection of 2-chloro-11 (2-dimethylaminoethoxy)-dibenzo[b,f]-thiepine (zotepine), thioridazine and haloperidol into the striatum and nucleus accumbens on stereotypic behaviour and motor activity. Lai H, Carino MA, Sperry R, Horita A. J Pharm Pharmacol; 1981 Apr 16; 33(4):252-4. PubMed ID: 6115914 [No Abstract] [Full Text] [Related]
18. [Locomotor activity and the nucleus accumbens]. Morgenstern R, Gold R, Oelssner W. Biomed Biochim Acta; 1983 Apr 16; 42(7-8):947-53. PubMed ID: 6651811 [Abstract] [Full Text] [Related]